Literature DB >> 22229815

Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization.

R I Monsalve1, A Vega, L Marqués, A Miranda, J Fernández, V Soriano, S Cruz, C Domínguez-Noche, L Sánchez-Morillas, M Armisen-Gil, R Guspí, D Barber.   

Abstract

BACKGROUND: Cross-reactivity between hymenoptera species varies according to the different allergenic components of the venom. The true source of sensitization must therefore be established to ensure the efficacy of venom immunotherapy.
OBJECTIVE: In the Mediterranean region, Polistes dominulus and Vespula spp. are clinically relevant cohabitating wasps. A panel of major vespid venom allergens was used to investigate whether serum-specific IgE (sIgE) could be used to distinguish sensitization to either vespid.
METHODS: Fifty-nine individuals with allergic reactions to vespid stings and positive ImmunoCAP and/or intradermal tests to vespid venoms were studied. sIgE against recombinant and natural venom components from each wasp species was determined using the ADVIA Centaur(®) system.
RESULTS: sIgE against recombinant antigen 5s sensitization to be detected in 52% of the patients tested (13/25). The sensitivity increased to 80% (20/25), when using natural antigen 5s, and to 100% with the complete panel of purified natural components, because the sIgE was positive to either the antigen 5s (Pol d 5/Ves v 5) or to the phospholipases (Pol d 1/Ves v 1) of the two vespids, or to both components at the same time. In 69% of cases, it was possible to define the most probable sensitizing insect, and in the rest, possible double sensitization could not be excluded. Vespula hyaluronidase was shown to have no additional value as regards the specificity of the assay.
CONCLUSIONS: The major allergens of P. dominulus' and Vespula vulgaris' venom, namely phoshpholipases and antigen 5s, are required to discriminate the probable sensitizing species in vespid-allergic patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229815     DOI: 10.1111/j.1398-9995.2011.02781.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  22 in total

1.  Improved production of the recombinant phospholipase A1 from Polybia paulista wasp venom expressed in bacterial cells for use in routine diagnostics.

Authors:  Amilcar Perez-Riverol; Alexis Musacchio-Lasa; Luis Gustavo Romani Fernandes; Jose Roberto Aparecido Dos Santos-Pinto; Franciele Grego Esteves; Murilo Luiz Bazon; Ricardo de Lima Zollner; Mario Sergio Palma; Márcia Regina Brochetto-Braga
Journal:  3 Biotech       Date:  2020-04-27       Impact factor: 2.406

Review 2.  Component Resolved Diagnosis in Hymenoptera Anaphylaxis.

Authors:  D Tomsitz; K Brockow
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.806

Review 3.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

4.  [Cross reactions between Hymenoptera venoms from different families, genera and species].

Authors:  W Hemmer
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

Review 5.  Overview of component resolved diagnostics.

Authors:  Regina Treudler; Jan C Simon
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 6.  Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens.

Authors:  Amilcar Perez-Riverol; Débora Lais Justo-Jacomini; Ricardo de Lima Zollner; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2015-07-09       Impact factor: 4.546

Review 7.  Anaphylaxis to insect venom allergens: role of molecular diagnostics.

Authors:  Markus Ollert; Simon Blank
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 8.  Hymenoptera allergens: from venom to "venome".

Authors:  Edzard Spillner; Simon Blank; Thilo Jakob
Journal:  Front Immunol       Date:  2014-02-28       Impact factor: 7.561

Review 9.  Component resolved diagnosis: when should it be used?

Authors:  Olga Luengo; Victòria Cardona
Journal:  Clin Transl Allergy       Date:  2014-09-08       Impact factor: 5.871

Review 10.  Stinging insect allergy: current perspectives on venom immunotherapy.

Authors:  Sian W Ludman; Robert J Boyle
Journal:  J Asthma Allergy       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.